Stephen J Luen

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Breast Cancer Risk

Endoplasmic Reticulum

Top Venues

JCO precision oncology

Nature reviews. Clinical oncology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Angela Mweempwa, Huiling Xu, Joseph H A Vissers, Richard W Tothill, Andrew D Pattison, Andrew P Fellowes, David M Thomas, Gary Richardson, Rodney John Hicks, Sean M Grimmond, Stephen B Fox, Stephen J Luen, Jayesh Desai, Benjamin J Solomon
Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. JCO precision oncology 5 (2022)
Peter Savas, Louisa L Lo, Stephen J Luen, Elizabeth F Blackley, Jason Callahan, Kate Moodie, Courtney T van Geelen, Yi-An Ko, Chen-Fang Weng, Lironne Wein, Maria João Silva, Andjelija Zivanovic Bujak, Miriam M Yeung, Sarah Ftouni, Rodney John Hicks, Prudence A Francis, Chee Khoon Lee, Sarah-Jane Dawson, Sherene Loi
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study. Cancer discovery 12 (9) (2022)
Ann Byrne, Peter Savas, Sneha Sant, Ran Li, Balaji Virassamy, Stephen J Luen, Paul A Beavis, Laura K Mackay, Paul J Neeson, Sherene Loi
Tissue-resident memory T cells in breast cancer control and immunotherapy responses. Nature reviews. Clinical oncology 17 (6) (2020)